Osmetech, Inc Company Profile
Osmetech plc is an AIM-listed public company on the London Stock Exchange.Osmetech is a fast developing, international diagnostics business with operations in Atlanta, Boston and Pasadena in the US, serving the high growth, near patient testing market targeting small to medium sized hospitals.
The growing OPTI range of blood gas and electrolyte products acquired from Roche Diagnostics in April 2003 provides a high quality and reliable revenue base. Its established operational infrastructure and strong international distributor network gives the Group an excellent platform to support the further growth of its business.
The acquisitions of Molecular Sensing plc in October 2004 and Clinical Micro Sensors, Inc. in July 2005 have provided a strong combination of products suitable for the rapidly growing molecular diagnostics market.
235 Hembree Park Drive
United States of America
Phone: 1 (770) 510-4444
Fax: 1 (770) 510-4445
Molecular diagnostics company GenMark Diagnostics Inc. (NASDAQ:GNMK) raised $42 million through the sale of 10 million shares at $4.20 in a follow-on underwritten by JPMorgan; William Blair; and Canac...
Drugs and Medications
Osmetech plc is an AIM-listed public company on the London Stock Exchange.Osmetech is a fast developing, international diagnostics business with operations in Atlanta, Boston and Pasadena in the US, s...
GenMark, a provider of automated, multiplex molecular diagnostic testing systems, detects and measures DNA and RNA targets to diagnose disease and to optimize the treatment of pat...
More Information about "Osmetech, Inc" on BioPortfolio
We have published hundreds of Osmetech, Inc news stories on BioPortfolio along with dozens of Osmetech, Inc Clinical Trials and PubMed Articles about Osmetech, Inc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Osmetech, Inc Companies in our database. You can also find out about relevant Osmetech, Inc Drugs and Medications on this site too.